- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Pharmacokinetics, Plasma Concentrations & Clinical Relevance

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Pharmacokinetics, Plasma Concentrations & Clinical Relevance
This is a Virtual Event for PsychU members in Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota and Wisconsin.
Pharmacokinetics refers to the study of how drugs are processed by the body. These processes play an important role in mental health treatments, and can vary due to several factors, ultimately impacting treatment of mental health. In this presentation, we will first provide an overview of pharmacokinetics and pharmacodynamics. Then, we will discuss the differences between pharmacokinetics based on different medication formulations, including the differences between oral and long-acting injectable formulations. Finally, the importance of pharmacokinetics and plasma concentration monitoring will be discussed as it relates to the clinical setting.

Heather Fields, PharmD, MPH, BCACP (OPDC)
Medical Science Liaison

Maria Perez, PharmD, AAHIVP
Medical Science Liaison – Digital Therapeutics
Speakers Heather Fields, PharmD, MPH, BCACP and Maria Perez, PharmD, AAHIVP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)